Controversial results are reported due to its expression in the tumor cells and the stromal compartment, but Enriquez et al. unveiled that castration triggers a tumor–stroma crosstalk leading to stromal Sparc downregulation that could be a crucial step for Neuroendocrine prostate cancer (NEPC), supporting its role as a new potential biomarker. Here, SPARC is linked to neoplasm.